DA, S., D, B., JL, M., CF, M., DF, B., JB, S., . . . WL, I. (2021). Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy. Journal of viral hepatitis, 28(9), 1256. https://doi.org/10.1111/jvh.13549
Chicago Style (17th ed.) CitationDA, Smith, et al. "Real World SOF/VEL/VOX Retreatment Outcomes and Viral Resistance Analysis for HCV Patients with Prior Failure to DAA Therapy." Journal of Viral Hepatitis 28, no. 9 (2021): 1256. https://doi.org/10.1111/jvh.13549.
MLA (9th ed.) CitationDA, Smith, et al. "Real World SOF/VEL/VOX Retreatment Outcomes and Viral Resistance Analysis for HCV Patients with Prior Failure to DAA Therapy." Journal of Viral Hepatitis, vol. 28, no. 9, 2021, p. 1256, https://doi.org/10.1111/jvh.13549.